KLK3 and prostate carcinoma: Prostate cancer detection primarily relies on prostate-specific antigen-magnetic resonance imaging-biopsy combinations, though the screening sensitivity (0.93) and specificity (0.20) underscore limitations and adherence challenges [24-27].